We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Molecular Biomarkers Pave Way for New Tests to Diagnose and Predict Breast Cancer

By LabMedica International staff writers
Posted on 20 Jun 2025

Despite playing essential roles in tissue development and immune protection, the contribution of proteoglycans in cancer remains poorly understood. More...

Some proteoglycans appear to shield the body from cancer, while others can accelerate tumor growth. This lack of clarity presents a diagnostic and therapeutic challenge, particularly in breast cancer. Now, researchers have uncovered specific patterns of proteoglycan expression linked to breast cancer, offering a potential pathway to more accurate diagnostics and targeted treatments.

The research was conducted by scientists at Thomas Jefferson University (Philadelphia, PA, USA), who sought to explore the role of proteoglycans in breast cancer development and progression. By analyzing genetic data from over 1,000 tumor tissue samples, the team aimed to better understand how these large biomolecules behave in malignancies. Using a machine learning algorithm, the team identified two distinct proteoglycan expression profiles in tumor tissues. One group of proteoglycans was found at elevated levels in tumors, while the other was significantly reduced. Importantly, these patterns correlated with disease severity—proteoglycans that promote cell proliferation were linked to more aggressive tumors, whereas those that suppress cell growth were associated with less malignant tumors.

The findings, published in Proteoglycan Research, open the door to practical applications in both diagnostics and treatment. The researchers suggest that these proteoglycan patterns could be used to develop more precise diagnostic tests and prognostic tools, enabling physicians to tailor treatment strategies more effectively based on tumor aggressiveness. Looking ahead, the team plans to investigate whether these proteoglycan biomarkers are relevant in other cancers, such as those affecting the skin, pancreas, and colon. Additionally, early-stage efforts are underway to develop an injectable proteoglycan-based therapy designed to prevent cancer metastasis—potentially marking a major step forward in cancer care.

“It’s the first comprehensive study on proteoglycans in breast cancer,” said Thomas Jefferson University researcher Renato Iozzo, MD, who led the research. “It is absolutely fundamental to have better biomarkers for breast cancer. This is really the beginning.”

Related Links:
Thomas Jefferson University


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.